ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety And Efficacy Of Azacitidine, and Lenalidomide In Higher Risk Myelodysplastic Syndrome (ViLen 001)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01053806
Recruitment Status : Unknown
Verified September 2012 by Tel-Aviv Sourasky Medical Center.
Recruitment status was:  Recruiting
First Posted : January 21, 2010
Last Update Posted : September 25, 2012
Sponsor:
Information provided by:
Tel-Aviv Sourasky Medical Center

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Unknown
  Estimated Primary Completion Date : March 2014
  Study Completion Date : No date given